Get started
Author

H Schulze

Observed names: H. Schulze, Hermann Schulze
ORCID: 0000-0002-5700-8578
Observed ORCID: 0000-0002-5700-8578
OpenAlex ID: A5088970493
Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease - a prospective multicenter observational study
2016 · A. Stallmach, C. Langbein, et al. · Alimentary Pharmacology & Therapeutics · 166
Early Ultrasound Response and Progressive Transmural Remission After Treatment With Ustekinumab in Crohn’s Disease
2022 · Torsten Kucharzik, Rune Wilkens, et al. · Clinical Gastroenterology and Hepatology · 109
PDF
Moderate endurance and muscle training is beneficial and safe in patients with quiescent or mildly active Crohn’s disease
2020 · Wolfgang Alexander Seeger, Juliane Thieringer, et al. · United European Gastroenterology Journal · 55
PDF
Review article: the management of Crohn's disease and ulcerative colitis during pregnancy and lactation
2014 · H. Schulze, P. Esters, et al. · Alimentary Pharmacology & Therapeutics · 55
A prospective cohort study to assess the relevance of vedolizumab drug level monitoring in IBD patients
2018 · Hermann Schulze, Philip Esters, et al. · Scandinavian Journal of Gastroenterology · 36
Novel Approaches Identifying Relevant Patient-Reported Outcomes in Patients With Inflammatory Bowel Diseases—LISTEN 1
2021 · Niels Teich, Hermann Schulze, et al. · Crohn s & Colitis 360 · 15
PDF
A Prospective Cohort Study to Assess the Relevance of Vedolizumab Drug Level Monitoring in IBD Patients
2017 · Hermann Schulze, Philip Esters, et al. · Gastroenterology · 7
P717 Comparison of two different techniques to assess vedolizumab trough levels in adult patients with IBD
2018 · C Berger, C Christ, et al. · Journal of Crohn s and Colitis · 2
P625 Electronic patient-reported outcomes in Inflammatory Bowel Diseases on vedolizumab therapy: Interim analysis of the non-interventional German LISTEN II study
2024 · N Teich, A Stallmach, et al. · Journal of Crohn s and Colitis · 1
PDF
P415 Real-world data in Inflammatory Bowel Diseases on vedolizumab therapy: Interim analysis of the non-interventional LISTEN II study
2023 · A Stallmach, H Schulze, et al. · Journal of Crohn s and Colitis · 1
PDF
A prospective cohort study to assess the relevance of Vedolizumab drug level monitoring in IBD patients
2017 · H Schulze, P Esters, et al. · Zeitschrift für Gastroenterologie · 1
P474 An enzyme-linked immunosorbent assay for therapeutic drug monitoring of vedolizumab
2017 · C. Berger, J. Semmler, et al. · Journal of Crohn s and Colitis · 1
P521 A prospective cohort study to assess the relevance of Vedolizumab drug level monitoring in IBD patients
2017 · H. Schulze, P. Esters, et al. · Journal of Crohn s and Colitis · 1
P326 Efficacy of vedolizumab on patient-reported outcomes in ulcerative colitis patients: results from a prospective German observational study
2017 · C. Schmidt, C. Langbein, et al. · Journal of Crohn s and Colitis · 1
Letter: a case supporting the use of rescue infliximab therapy for fulminant ulcerative colitis in pregnancy – authors’ reply
2015 · H. Schulze, P. Esters, et al. · Alimentary Pharmacology & Therapeutics · 1
Entzündliche Erkrankungen des Dünn- und Dickdarms
2015 · Bernhard Lembcke, Hermann Schulze, et al. · Springer eBooks · 1
Nässende Läsion an der Brust – ein ungewöhnlicher Fall
2023 · Petia Kiene, Hermann Schulze, et al. · Die Gynäkologie
Klinische und patientenberichtete Daten aus der Behandlungspraxis mit Vedolizumab bei chronisch entzündlichen Darmerkrankungen (CED): Eine prospektive, nicht-interventionelle Studie in Deutschland (LISTEN II)
2022 · A Stallmach, H Schulze, et al. · Zeitschrift für Gastroenterologie
Identifizierung relevanter patientenberichteter Endpunkte bei Patienten mit chronisch entzündlichen Darmerkrankungen - LISTEN I
2020 · H Schulze, N Teich, et al. · Zeitschrift für Gastroenterologie
Morbus Crohn an der Brust
2020 · P Kiene, V van Haasteren, et al. · Geburtshilfe und Frauenheilkunde
Morbus Crohn an der Brust
2020 · P Kiene, V van Haasteren, et al. · Senologie - Zeitschrift für Mammadiagnostik und -therapie
Sa1794 MODERATE ENDURANCE- AND MUSCLE TRAININING IS SAFE TO PERFORM FOR PATIENTS WITH QUIESCENT OR MILD ACTIVE CROHNS DISEASE AND INCREASES THEIR STRENGTH
2020 · Wolfgang A. Seeger, Juliane Thieringer, et al. · Gastroenterology
P363 Moderate endurance and muscle training are safe to perform for patients with quiescent or mild active Crohn’s disease and increases their strength
2020 · W A Seeger, J Thieringer, et al. · Journal of Crohn s and Colitis
PDF
A75 Comparison of Two Different Assessment Techniques for Measurement of Vedolizumab Trough Levels in Adult Patients With Ibd
2019 · K Farrag, C Berger, et al. · Journal of the Canadian Association of Gastroenterology
Vedolizumab in der Therapie chronisch-entzündlicher Darmerkrankungen: Klinische Wirksamkeit und Sicherheit nach 12 Monaten
2016 · C Langbein, R Atreya, et al. · Zeitschrift für Gastroenterologie
Works count: 32
Citation count: 453
H-index: 7
I10-index: 6
Year
Topic
Type